| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |